Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

[Metformin as a key to alternative activation of microglia?].

Łabuzek K, Gabryel B, Okopień B.

Postepy Hig Med Dosw (Online). 2014;68(0):247-57. Polish.

PMID:
24988623
[PubMed - in process]
2.

Pharmacokinetic Interaction Between Rosuvastatin and Metformin in Healthy Korean Male Volunteers: A Randomized, Open-Label, 3-Period, Crossover, Multiple-Dose Study.

Lee D, Roh H, Son H, Jang SB, Lee S, Nam SY, Park K.

Clin Ther. 2014 Jun 26. pii: S0149-2918(14)00360-9. doi: 10.1016/j.clinthera.2014.06.004. [Epub ahead of print]

PMID:
24976448
[PubMed - as supplied by publisher]
3.

Neuro, cardio, and reno protective activities of rosuvastatin in streptozotocin-induced type 2 diabetic rats undergoing treatment with metformin and glimepiride.

Rondi S, Peddolla R, Venisetty RK.

J Adv Pharm Technol Res. 2014 Apr;5(2):78-83. doi: 10.4103/2231-4040.133429.

PMID:
24959416
[PubMed]
Free PMC Article
4.

The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model.

Mao-Ying QL, Kavelaars A, Krukowski K, Huo XJ, Zhou W, Price TJ, Cleeland C, Heijnen CJ.

PLoS One. 2014 Jun 23;9(6):e100701. doi: 10.1371/journal.pone.0100701. eCollection 2014.

PMID:
24955774
[PubMed - in process]
Free PMC Article
5.

Effect of vitamin D3 on behavioural and biochemical parameters in diabetes type 1-induced rats.

Calgaroto NS, Thomé GR, da Costa P, Baldissareli J, Hussein FA, Schmatz R, Rubin MA, Signor C, Ribeiro DA, Carvalho FB, de Oliveira LS, Pereira LB, Morsch VM, Schetinger MR.

Cell Biochem Funct. 2014 Jun 19. doi: 10.1002/cbf.3044. [Epub ahead of print]

PMID:
24947461
[PubMed - as supplied by publisher]
6.

Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.

Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Ellis KA, Bush AI, Faux NG, Watters DA.

Diabetes Care. 2014 Jun;37(6):e151. doi: 10.2337/dc14-0278. No abstract available.

PMID:
24855179
[PubMed - in process]
7.

Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.

Pérez-Revuelta BI, Hettich MM, Ciociaro A, Rotermund C, Kahle PJ, Krauss S, Di Monte DA.

Cell Death Dis. 2014 May 8;5:e1209. doi: 10.1038/cddis.2014.175.

PMID:
24810045
[PubMed - in process]
Free PMC Article
8.

Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice.

Zhao RR, Xu XC, Xu F, Zhang WL, Zhang WL, Liu LM, Wang WP.

Biochem Biophys Res Commun. 2014 Jun 13;448(4):414-7. doi: 10.1016/j.bbrc.2014.04.130. Epub 2014 May 4.

PMID:
24802403
[PubMed - in process]
9.

Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients.

Huang YC, Hsu CC, Lin WC, Yin TK, Huang CW, Wang PW, Chang HH, Chiu NT.

ScientificWorldJournal. 2014 Mar 24;2014:694326. doi: 10.1155/2014/694326. eCollection 2014.

PMID:
24782665
[PubMed - in process]
Free PMC Article
10.

Glioblastoma stem cells: a new target for metformin and arsenic trioxide.

Carmignani M, Volpe AR, Aldea M, Soritau O, Irimie A, Florian IS, Tomuleasa C, Baritchii A, Petrushev B, Crisan G, Valle G.

J Biol Regul Homeost Agents. 2014 Jan-Mar;28(1):1-15. Review.

PMID:
24750786
[PubMed - indexed for MEDLINE]
11.

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.

Zhou K, Donnelly L, Yang J, Li M, Deshmukh H, Van Zuydam N, Ahlqvist E; Wellcome Trust Case Control Consortium 2, Spencer CC, Groop L, Morris AD, Colhoun HM, Sham PC, McCarthy MI, Palmer CN, Pearson ER.

Lancet Diabetes Endocrinol. 2014 Jun;2(6):481-7. doi: 10.1016/S2213-8587(14)70050-6. Epub 2014 Mar 19.

PMID:
24731673
[PubMed - in process]
Free PMC Article
12.

Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.

Lexis CP, van der Horst IC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel AF, van der Werf HW, Schurer RA, Pundziute G, Tan ES, Nieuwland W, Willemsen HM, Dorhout B, Molmans BH, van der Horst-Schrivers AN, Wolffenbuttel BH, ter Horst GJ, van Rossum AC, Tijssen JG, Hillege HL, de Smet BJ, van der Harst P, van Veldhuisen DJ; GIPS-III Investigators.

JAMA. 2014 Apr 16;311(15):1526-35. doi: 10.1001/jama.2014.3315.

PMID:
24687169
[PubMed - indexed for MEDLINE]
13.

Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain.

Naseer MI, Ullah I, Narasimhan ML, Lee HY, Bressan RA, Yoon GH, Yun DJ, Kim MO.

Cell Death Dis. 2014 Mar 27;5:e1150. doi: 10.1038/cddis.2014.53.

PMID:
24675468
[PubMed - in process]
Free PMC Article
14.

Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress.

Alzoubi KH, Khabour OF, Al-Azzam SI, Tashtoush MH, Mhaidat NM.

Curr Neuropharmacol. 2014 Mar;12(2):186-92. doi: 10.2174/1570159X11666131120223201.

PMID:
24669211
[PubMed]
15.

[Metformin as a key to alternative activation of microglia?].

Łabuzek K, Gabryel B, Okopień B.

Postepy Hig Med Dosw (Online). 2014 Mar 7;68:247-57. Polish.

PMID:
24662793
[PubMed - in process]
16.

Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.

Lin HC, Hsu YT, Kachingwe BH, Hsu CY, Uang YS, Wang LH.

J Clin Pharm Ther. 2014 Mar 24. doi: 10.1111/jcpt.12151. [Epub ahead of print]

PMID:
24661226
[PubMed - as supplied by publisher]
17.

Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke.

Venna VR, Li J, Hammond MD, Mancini NS, McCullough LD.

Eur J Neurosci. 2014 Jun;39(12):2129-38. doi: 10.1111/ejn.12556. Epub 2014 Mar 21.

PMID:
24649970
[PubMed - in process]
18.

Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke.

Jin Q, Cheng J, Liu Y, Wu J, Wang X, Wei S, Zhou X, Qin Z, Jia J, Zhen X.

Brain Behav Immun. 2014 Mar 12. pii: S0889-1591(14)00069-5. doi: 10.1016/j.bbi.2014.03.003. [Epub ahead of print]

PMID:
24632338
[PubMed - as supplied by publisher]
19.

Diabetes drugs and neurological disorders: new views and therapeutic possibilities.

Patrone C, Eriksson O, Lindholm D.

Lancet Diabetes Endocrinol. 2014 Mar;2(3):256-62. doi: 10.1016/S2213-8587(13)70125-6. Epub 2013 Nov 22.

PMID:
24622756
[PubMed - in process]
20.

Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy.

Jiang T, Yu JT, Zhu XC, Wang HF, Tan MS, Cao L, Zhang QQ, Gao L, Shi JQ, Zhang YD, Tan L.

Br J Pharmacol. 2014 Jul;171(13):3146-57. doi: 10.1111/bph.12655.

PMID:
24611741
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk